Montreal, Canada
Aplantex, founded in 2019, operates from its headquarters in Canada, embodying its slogan, "Innovation: the core of our DNA." This company targets the Manufacturing and Pharmaceutical industries with a focus on creating high-value plant-based active ingredients for the pharmaceutical, cosmetics, and agri-food markets.
A key differentiator for Aplantex is its proprietary technology centered on advancements in the "omics" field. This technology enables a practical, cost-effective, and scalable industrial process, optimizing the metabolism of photosynthetic phytoreplicators. This positions Aplantex to meet diverse client demands in the phytochemical ingredients' market.
Noteworthy is the company’s recent $3.30M Series A investment, received on 14 February 2024, highlighting investor confidence in their innovative approach and growth potential. As they scale operations, their robust academic and industrial partnerships are pivotal for future expansion.
